Error: Could not add to watchlist. X
+ Watchlist

AXA Framlington Biotech Fund

FRABIOA:LN
163.40
GBp
0.90
0.55%
As of 12:59 AM EDT 3/24/2017
Fund Type
Unit Trust
52Wk Range
123.90 - 175.60
1 Yr Return
24.92%
YTD Return
5.01%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Previous Close
164.30
52Wk Range
123.90 - 175.60
1 Yr Return
24.92%
YTD Return
5.01%
Fund Type
Unit Trust
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 03/24/2017)
163.4
Total Assets (m GBP) (on 03/24/2017)
540.736
Inception Date
11/26/2001
Last Dividend (on 03/01/2017)
-
Dividend Indicated Gross Yield
-
Fund Managers
LINDEN THOMSON
Front Load Fee
5.50%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.75%
Expense Ratio
1.95%

Top Fund Holdings

Name Position Value % of Fund
839.12 k 48.36 m 9.20
517.72 k 47.84 m 9.10
222.54 k 45.21 m 8.60
364.08 k 37.85 m 7.20
246.30 k 30.49 m 5.80
261.68 k 25.23 m 4.80
353.99 k 24.18 m 4.60
77.25 k 22.08 m 4.20
286.55 k 19.98 m 3.80
156.84 k 19.98 m 3.80
Profile
AXA Framlington Biotech Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.
Address
AXA Framlington Unit Management Ltd
7 Newgate Street
London EC1A 7NX
United Kingdom
Phone
44-207-374-4100